Giuseppe S. Alvaro
Fondatore presso Autifony Therapeutics Ltd.
Profilo
Giuseppe S.
Alvaro is the founder and the Chief Research Officer at Autifony Therapeutics Ltd., a company founded in 2011.
He previously worked as the Director & Chemistry Leader at GSK Plc.
Dr. Alvaro holds a doctorate degree from Alma Mater Studiorum - Università di Bologna.
Posizioni attive di Giuseppe S. Alvaro
| Società | Posizione | Inizio |
|---|---|---|
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Fondatore | 24/08/2011 |
Precedenti posizioni note di Giuseppe S. Alvaro
| Società | Posizione | Fine |
|---|---|---|
| GSK PLC | Direttore/Membro del Consiglio | - |
Formazione di Giuseppe S. Alvaro
| Alma Mater Studiorum - Università di Bologna | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GSK PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Giuseppe S. Alvaro
